Tenax Therapeutics, Inc.
TENX
$5.80
$0.030.52%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -58.24% | -10.76% | 5.87% | -17.76% | -63.59% |
| Total Depreciation and Amortization | -- | -- | -- | -- | 410.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4,536.84% | -33.23% | -75.32% | 217.79% | -11.92% |
| Change in Net Operating Assets | 107.78% | 66.04% | 134.37% | -174.46% | 1,390.80% |
| Cash from Operations | -14.24% | -1.85% | 41.32% | -339.63% | 43.54% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 99.96% | -107.44% | -53.25% | 49.66% | -1.69% |
| Issuance of Common Stock | -- | -- | -100.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -4,922.08% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 29,348.91% | -- | 100.00% | -102.40% | 4,921.94% |
| Cash from Financing | -99.93% | 68,562.95% | -101.70% | 4,637.74% | -1.93% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -103.89% | 2,909.25% | -214.80% | 304.32% | 40.09% |